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Abstract
Background: While much research has been conducted on medication safety, few of these studies
have addressed primary care, despite the high volume of prescribing and dispensing of medicines
that occurs in this setting. Those studies that have examined primary care dispensing emphasised
the need to understand the role of sociotechnical factors (that is, the interactions between people,
tasks, equipment and organisational structures) in promoting or preventing medication incidents.
The aim of this study was to identify sociotechnical factors that community pharmacy staff
encounter in practice, and suggest how these factors might impact on medication safety.
Methods: Sixty-seven practitioners, working in the North West of England, took part in ten focus
groups on risk management in community pharmacy. The data obtained from these groups was
subjected to a qualitative analysis to identify recurrent themes pertaining to sociotechnical aspects
of medication safety.
Results: The findings indicated several characteristics of participants' work settings that were
potentially related to medication safety. These were broadly classified as relationships involving the
pharmacist, demands on the pharmacist and management and governance of pharmacists.
Conclusion: It is recommended that the issues raised in this study be considered in future work
examining medication safety in primary care.
Background
Medication safety has long been recognised as a key issue
within the broader patient safety agenda [1-3]. A number
of studies have shown that medication error is relatively
common and identified a range of contributory factors
occurring at the individual (for example, fatigue and train-
ing) and organisational (for example, staffing, organisa-
tional climate and system design) levels of analysis [4-6].
Much of this research has been conducted in secondary
care settings, with relatively few studies taking place in pri-
mary care, and fewer still focusing on the dispensing of
medicines in community pharmacy. However, a large pro-
portion of medication prescribing and dispensing occurs
in primary care settings [3]. The British National Health
Service [7] reports that approximately 11,000 community
pharmacies existed in England and Wales, dispensing
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approximately 785 million prescription items each year.
While there is no population-level estimate for the inci-
dence of adverse events in primary care dispensing, a pro-
spective self-report study in a sample of 35 British
community pharmacies found an incidence rate of 22
near misses and four errors for every 10,000 items dis-
pensed [8]. A similar error rate (0.26%) was found in an
observational study of a single pharmacy in the United
States [9]. In both cases, errors were attributed to a range
of factors, including misidentification of drugs, workload,
distractions and dispensing against product labels created
during the process rather than against the prescription
itself. Meanwhile, Peterson, Wu & Bergin [10] note con-
cerns among Australian community pharmacists that an
increase in workload is creating more opportunities for
dispensing errors to occur, and Szeinbach, Seoane-
Vazquez, Parekh & Herderick [11] found a relationship
between volume of prescriptions and frequency of dis-
pensing errors in a self-report survey of US community
pharmacists.
These studies highlight the need to address what have
been termed "sociotechnical" factors in medication safety.
Sociotechnical factors are those concerning the relation-
ship between the technical, psychological and social ele-
ments of a work system [12]. Their relevance to
community pharmacy is illustrated by Ashcroft, More-
croft, Parker & Noyce [13], who note the influence of both
technical elements (such as workload and staffing) and
social elements (attitudes towards incident reporting and
organisational learning) on the proliferation of medica-
tion incidents. During their investigation, Ashcroft et al.
collected qualitative data from a sample of community
pharmacy staff. Their analysis of this data, though,
focused only on reporting and learning from medication
incidents, their aim being to develop a safety culture
assessment tool [13,14]. The aim of the present study is to
extend Ashcroft et al.'s initial work by identifying socio-
technical factors that participants felt were related to med-
ication safety in general - that is, the causation, detection
and prevention of medication incidents as well as their
reporting.
Method
The authors carried out a secondary analysis of the quali-
tative data collected for Ashcroft et al.'s [13] study; the
original aim of which was to explore participants' views
about risk management culture in community pharmacy.
The data was collected from ten focus groups conducted
in the North West of England between December 2003
and April 2004. These focus groups involved a total of 67
participants, all working in community pharmacy. Partic-
ipants were recruited on a purposive basis, having taken
part in a previous questionnaire study by the authors and
consented to be contacted about further research. The par-
ticipants represented a range of roles and locations across
the region, as shown in Table 1. Ethical approval for the
research was granted by the University of Manchester Sen-
ate Committee.
Each focus group lasted for approximately two hours and
was moderated by an experienced qualitative researcher.
The topic guide was semi-structured, and included the fol-
lowing themes:
• What are the attitudes and views of pharmacists and
support staff about patient safety in community phar-
macy?
Table 1: Composition of focus groups
Group Pharmacists Pre-registration pharmacists Support staff
Owner Employed Locum
11 6
22 4
37 1
44
5 9
61 3
7 4
8231 1
91 0
10 8
Total N 10 11 31 10 5
% of sample 14.9 16.5 46.3 14.9 7.4
Note: "Locum" is the UK term for sessional pharmacists. "Pre-registration" is the UK term for trainee pharmacists. "Support staff" is a collective 
term for counter assistants and non-pharmacist dispensers.BMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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￿ What is the prevailing culture with respect to patient
safety in community pharmacy?
￿ How does the prevailing culture affect how incidents
are handled?
￿ What types of incidents are reported/not reported in
community pharmacy?
￿ What factors facilitate and inhibit reporting?
As well as these themes, other discussion topics were
allowed to emerge spontaneously during each focus
group. All focus group discussions were tape recorded and
fully transcribed for subsequent analysis.
Two researchers (DLP and DMA) identified themes rele-
vant to the sociotechnical aspects of community phar-
macy using template analysis [15,16]. Template analysis is
an inductive process that involves the analyst reading
through the data and creating a "template" consisting of
the general themes that emerge from this reading. The
template is then modified and extended through succes-
sive readings until it provides sufficient coverage of the
data. In the current study, the researchers began by read-
ing the entire dataset and identifying the general issues
that participants raised in relation to medication safety.
These issues became the superordinate themes. They were
used as a framework to categorise the data from each focus
group, following which each theme was developed by
identifying subordinate themes in the data assigned to it.
Version 7 of NVivo [17] was used to document the analy-
sis, which continued until the analysts had identified as
many themes as possible from the data. As DLP and DMA
worked separately to identify superordinate themes, relia-
bility of the analysis was established by comparing the
two set of themes for consistency, with the final template
incorporating both sets; this being a common approach to
establishing reliability in qualitative studies that use a
realist epistemological framework [18]. The final tem-
plate, consisting of the superordinate and subordinate
themes, was reviewed by PRN and DP to confirm the rel-
evance of the themes to medication safety.
Results and discussion
Across all of the focus groups, the factors thought to affect
medication safety were summarised using three superor-
dinate themes: relationships involving the pharmacist;
demands on the pharmacist; managing pharmacy work.
These themes, and their subordinate themes, are listed in
Table 2.
Relationships involving the pharmacist
The first theme - relationships involving the pharmacist -
reflected the interdependencies and interactions between
the pharmacist and other people. These include peers,
other health care professionals outside the pharmacy, and
service users.
Peers
Pharmacists highlighted the role of their professional
peers in maintaining safe practice. As with other profes-
sional groups, collective norms of practice may emerge
amongst pharmacists. However, while some of these
norms may encourage safe practice, others may discour-
age it.
[We] were taught, certainly in my era, at College, you did
not make mistakes, you covered them up, that was the his-
tory. I had a boss who I could have killed because he did
make mistakes but he refused to admit it. [...] [I] went in
to the dispenser and said "Look, ignore him, we all make
mistakes, we check each other" [Locum pharmacist, Group
9]
The effect of professional norms on safety-related behav-
iour has been noted in previous studies; for example,
anaesthetists' approaches to the use of guidelines are
influenced to some extent by how they expect their peers
to act [19,20]. Hence one of the ways to achieve medica-
tion safety is to encourage pharmacists to develop group
norms that support safe behaviour.
Other comments made by participants referred to per-
ceived differences between agency-supplied (locum)
pharmacists and permanent (employed) pharmacists
with regard to involvement in pharmacy activities.
I [once] had an issue with methadone, [...] I did not agree
with what the pharmacists had done the previous week and
they'd done nothing about it all week when they had time
to sort it out and then they didn't even tell me in advance
of me going, I walk in on the Saturday and get stuck with
the real issue, do you give it, don't you give it. And you're
dealing with something that's quite, you know, can change
that person quite a lot, and you're thinking, "Well, where
do you stand?" [Locum pharmacist, Group 3]
The locum pharmacist talks of his disconnection from the
day-to-day activity of the pharmacy; this can lead to phar-
macists (whether employed full-time, part-time or locum)
being confronted with an ongoing or complex situation of
which they have only partial knowledge. This may
become more of a problem as pharmacies extend their
opening hours, increasing the need for shift handovers
between both pharmacists and support staff [21]. In any
case, there is perhaps a need for more documentation of
cases for the purposes of information sharing.BMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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Other health care professionals
Some participants commented on the relationship
between pharmacist and prescriber. In particular, issues
related to the partnership working that occurs between the
two, for example the pharmacist agreeing to dispense an
incomplete prescription on the understanding that the
prescriber will issue an amended version later. However,
there was also a fear on the part of pharmacists that they
would be blamed for medication incidents that actually
originated with the prescriber.
When a prescription comes into us we're relying on the fact
that the GP has made the correct diagnosis and has pre-
scribed a dose that is safe for that patient. [...] So [...]
you're already working, even with prescription medicines,
from half the song sheet, aren't you? [Pharmacy owner,
Group 10]
I would send [an incomplete prescription] back even if I
knew the doctor. If you accept it the first time and you keep
accepting it, [...] it'll happen again. [...] I'm just not going
to accept the responsibility for the doctor's mistake. [Locum
pharmacist, Group 1]
These excerpts point to a tension within the pharmacist-
prescriber relationship. On the one hand, pharmacists are
keen to protect their dispensing from substandard pre-
scribing, particularly if they may be held culpable for any
problems that result. On the other hand, pharmacists are
dependent on prescribers for their business, and so may
be reluctant to disrupt their working relationship. Bradley
et al. [22] have noted that trust in each others' capabilities
is fundamental to collaborative working between phar-
macists and GPs. It could be hypothesised that the extent
to which both parties are willing to collaborate over
Table 2: Sociotechnical factors related to medication safety
General themes Subordinate themes
(i) Relationships involving the pharmacist:
Peers Group norms
Involvement of locums
Other health care professionals Collaboration with prescribers
Pharmacist involvement in governance
Patients/customers Customer demands
Trust in pharmacist
Patient as final safety barrier
Informing patients about safety issues
(ii) Demands on the pharmacist:
Commercial Profitability vs safety
Financial dependencies
Budgetary constraints
Corporate Approach to governance
Organisational culture
Hierarchy and protection
Legal and regulatory Legal and regulatory sanctions
Following the law vs meeting demands
Support from regulator
Regulator enforcing standards
(iii) Management and governance:
Blame culture vs learning culture Allocating/accepting blame
Learning from experience
Openness and trust
Being the target of blame
Formal vs informal processes Monitoring and audit
Reporting and feedback
Trust and engagement in governance
Communities of practice
Protocols Quality assurance
Individuality and professional autonomy
Credibility and practicality
Doing what's best for the patient
Work design Human-computer interaction
Workspace
AutomationBMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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safety-related issues (for example by holding each other
mutually accountable for adhering to prescribing proce-
dures) is determined by the level of interpersonal or pro-
fessional trust that they have in each other.
Patients/customers
Several participants implied a role for the patient as a
safety barrier, as there were situations in which the patient
forestalled a potential adverse event by identifying an
incorrectly dispensed medicine. However, while some
participants felt that it would be useful to involve the pub-
lic in safety issues, others were reluctant to do so because
of a fear that this would erode patients' trust in the phar-
macy.
I [once] called the name, didn't ask the address, spent ten
minutes counselling [the patient] on how to use an inhaler
and [he] came back and said "This is the wrong thing. I
was expecting tablets". [...] That was my mistake, [but]
that goes to show you how much he was listening [Locum
pharmacist, Group 1]
We want to [...] expand our role, and if the patients aren't
gonna have any confidence in us in like medication reviews
and prescribing, if they think we're not as competent [...].
That's my concern, I just don't want them to lose confidence
in us because I want pharmacists to do those extended roles
[Employed pharmacist, Group 4]
It is interesting to consider where the power lies in the
pharmacist-customer relationship. From one point of
view, the pharmacist has a basis for power, as it is he or
she rather than the customer who has insight about per-
formance and safety issues in the pharmacy, as well as
being the one who is responsible for managing any inter-
actions with the customer. However, some of the com-
ments made suggest that the customer has some influence
over the pharmacist; the latter perceives pressure to turn
around medicines quickly for the customer. This may be
of particular relevance to medication safety given that one
source of high workload could be the perceived or actual
productivity demands from customers, as well as interrup-
tions to the pharmacist [10].
I think we've got to get away from the idea that a good phar-
macist in the view of the public is one who gets the medica-
tion out quickly. [...] They just assume that it's going to be
correct but they don't rank the actual quality of the dispens-
ing in any of it, they put speed at the top [Locum pharma-
cist, Group 9]
I've got an open plan pharmacy, and I've got people right
over the top and talk about interruptions. [...] It takes your
whole attention away. [...] The patient can be the biggest
distraction you have [Pharmacy owner, Group 10]
Incidentally, there is some debate in the literature about
how, and how much, patients should be formally
involved in medication checking. Lyons [23] argues that,
from a safety engineering perspective, it would be difficult
to ensure that patients provided a consistent and reliable
safety check, given the diversity of patients and a possible
unpreparedness to take responsibility for safety of their
treatment. However, Entwistle [24] argues that, from a
medical ethics perspective, it would be beneficial to
involve patients in the final check, even if it is impractical
to place complete reliance on them to do the check them-
selves, as this can enhance carer-patient communication
and provide an opportunity for patient education. The
extent to which patients should be involved in medicine
checking in community pharmacy, and how much phar-
macists want them to be involved, is a question that may
warrant further investigation.
Demands on the pharmacist
As well as interacting with different people and groups,
the community pharmacist operates within a number of
constraints. These arise both from business needs and
from the legal and regulatory context of practice.
Commercial
In the UK, community pharmacy differs from many other
healthcare services in that it operates as a private business,
rather than being government owned. This means that a
key concern for community pharmacists is the cost of
their services and the financial impact of any decisions
made in the course of their work. Commercial concerns
could potentially influence the attitude of pharmacists to
service provision.
We're gonna be [...] competing for money [from the Pri-
mary Care Trust] cos they're gonna have seventy five per-
cent of the budget and [...] we're gonna want their services,
so it might prevent us from being honest [with them] about
our mistakes and errors [Employed pharmacist, Group 4]
It's very hard to make it work when you've got [...] whistle-
blowers in two different sorts of organisation. Like non-
profit organisations like nurses and GPs, and pharmacists
in profit organisations, we're supposed to whistle-blow on
GPs if we see bad prescribing, but to the detriment of our
business? [Pharmacist, Group 8]
Staff is the single most expensive item in any business,
whether it be pharmacy or anywhere else, and all the firms
[...] are under pressure from their shareholders to make
more profit, and the easiest and quickest way to do that is
not increasing turnover, it's to cut down the staff [Locum
pharmacist, Group 9]BMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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The first two quotes concern the integration between com-
munity pharmacies and the not-for-profit sections of the
health service. The pharmacist in Group 4 expresses a
reluctance to report errors to the body that is responsible
for funding the pharmacy, while the pharmacist in Group
8 suggests that community pharmacists have more to lose
than do other healthcare providers by reporting others'
bad practice. Hence, the relationship between pharma-
cists and the safety management functions of the health
commissioning organisation may be influenced by the
pharmacists' need to protect their business. The third
comment refers to a perceived conflict between the need
to meet commercial targets and the need to ensure ade-
quate resources - in this case, staff. Shortage of staff,
though, may have adverse consequences for safety in the
face of increasing workload in pharmacies [4,10].
Corporate
In the UK, community pharmacies come in a number of
forms - some operate as independent stores; others as
small chains consisting of several stores; yet others as
larger regional or national chains, often integrated with a
general department store or supermarket. As organisa-
tions in general vary in terms of their culture and hence
operating practices [25], so do these different types of
pharmacy. In general, larger chains were seen as having a
more centralised approach, in which pharmacists at the
various chain locations were expected to take direction
from senior managers based in a headquarters.
I think the protocols that [chains] have as well tend to be
stricter [than in independents], and they won't let you bend
from the protocols [Employed pharmacist, Group 6]
No, because they've got so many branches to cover, they've
got to put it down as a must do, rather than a, well, we'll
get round it type of thing [Locum pharmacist, Group 6]
The advantage of notifying the Head Office [of a chain] is
that they then cascade the information to everybody so that
every store can then separate the Xalacom and Xalitan in
the fridge so that it doesn't happen, so you're actually avoid-
ing the error ever happening [Locum pharmacist, Group 9]
I think you tend to get more demoralised staff in a company
and more negative on feedback and communication to a
well run independent sometimes, because I think they're
sort of all put into a block and they can be boxed if you're
not careful in a company [Locum pharmacist, Group 1]
As the first two quotes suggest, the centralised approach of
pharmacy chains carries some benefits for safety manage-
ment. First, by establishing a managerial hierarchy and
formally defining standards of practice, it provides a form
of quality assurance. Second, the organisation may have
mechanisms for sharing resources and knowledge. How-
ever, the third quote surmises that differences in morale
and communication between staff may be found across
the different types of pharmacy. Whether this is the case is
not clear from the data in this study; however, Ashcroft &
Parker [26] suggest that staff commitment and communi-
cation (as well as resourcing) are amongst the factors asso-
ciated with safety in pharmacies. Hence, it would be of
value to evaluate the effect of organisational structures
and practices on safety.
Legal and regulatory
Pharmacy practice in the United Kingdom is governed
both by legislation such as the Medicines Act, and by the
regulations of the pharmacy professional body, which at
the time of writing is the Royal Pharmaceutical Society of
Great Britain. Hence there are statutory requirements by
which pharmacists need to abide. As autonomous practi-
tioners they are very sensitive to the risk of disciplinary
action or litigation should a patient be harmed. This
emerged as a key driver for safe practice.
Getting struck off the register, the thought of that, and as a
professional as well, not being able to practice. So it's all
kinds, you have a lot to lose as a pharmacist [Employed
pharmacist, Group 4]
It's all about going to court, isn't it, that's the last thing any-
body wants [Employed pharmacist, Group 4]
You get somebody coming back and say, [...] "I was owed
five bendrofluazide tablets." And there's absolutely no
record [...], somebody's [must have] made a mistake at this
end [...], so [...] you give it out. Now, technically that's
going against the law [...] [but] at the end of the day
there's a little bit of a grey area [Locum pharmacist, Group
6].
The pharmaceutical inspector [...] had a woman who was
on fentanyl patches [...]. The pharmacist actually lent her
a pack of five, on the understanding that the [...] surgery
[was] going to write the prescription. [...] [However, the]
surgery would then not provide a prescription. [...] [The
inspector] said there was no way I was going to jump on
him for giving those five patches which she'd been having
for [...] seven or eight months, because the pharmacist had
done the right thing by the patient [Locum pharmacist,
Group 6]
There was a general disinclination on the part of partici-
pants to incur the wrath of the law or the regulator. How-
ever, some participants described situations in which
pharmacists may feel they should "bend" the law, suggest-
ing a direct conflict between doing "the right thing" and
staying within legal boundaries. Interestingly, the lastBMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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quote suggests that the regulator may also play a role in
arbitrating between the two imperatives. Benson, Cribb
and Barber's study of pharmacy practitioners [27] also
described situations in which ethical responsibilities and
legal responsibilities were felt by the respondent to be in
conflict; however, the relative frequency of such situations
is not fully clear. Another issue to consider is which course
of action (legal or ethical) is felt by pharmacists to be most
closely aligned with safe practice.
A further potential role that participants identified for the
regulator is to negotiate with pharmacy employers and
drug manufacturers in order to ensure adequate resources
for safe practice.
We've been calling for [manufacturers to change] the pack-
aging and colour [coding] and all the rest of it, we've been
calling for this for years, and nothing's happening because
[...] no individual body has got sufficient clout, so it needs
to go to one central body to actually be able to say "Enough
is enough" [Locum pharmacist, group 9]
Management and governance
In order to manage the work of pharmacists, both their
employers and their professional regulator may make use
of a range of methods. These include governance proc-
esses such as incident reporting, regulating practice
through the use of protocols, and the physical design of
workplaces and tools. All of these can influence the work
of pharmacists as shown in the following examples.
Blame culture vs learning culture
Some of the participants recognised the benefits of devel-
oping a culture in which incidents were openly discussed
and lessons shared and acted upon. However, many par-
ticipants felt that a barrier to adopting such practices is a
tendency to attribute blame to individuals unnecessarily.
One of the issues [...] is getting rid of this blame culture.
Although we're trying to instil [that] it doesn't really matter
who did it, [...] let's move on and learn from it, people are
still very hung up on who actually committed the error
[Locum pharmacist, Group 9]
Even in our branch they say it doesn't matter if you've done
wrong, [...] just write your name down here but nobody
likes their name put down. [...] You get a bit paranoid, you
think [...] it's just your name there and you think you must
be absolute rubbish at your job [Pre-registration pharma-
cist, Group 5]
The effect of blame culture on safety management in
healthcare settings has been discussed in depth in previ-
ous literature [28]. Here, it will suffice to say that the com-
ments made by participants in this study are consistent
with the findings of previous studies; it would appear that
sensitivities about being seen to blame colleagues, or
being the subject of blame oneself, may provide a barrier
to exploring and learning from adverse events in phar-
macy practice [29].
Formal vs informal approaches
While there are usually formal governance processes -
mainly based on reporting and audit - some participants
alluded to the alternative use of informal approaches. For
example, a pharmacy store manager may, having found
out about a dispensing error, discuss it with the people
involved in the first instance, only resorting to formal
reporting if the matter cannot be resolved informally.
Also, some participants noted that their level of trust in
governance processes depends on who is administering
them.
Newly qualified [...], couple of days in, made a mistake,
and I told them and we talked about it, but I didn't report
it to head office, cos I knew that they were devastated [...]
I gotta think about this person and they would probably not
wanna be a pharmacist any more. [...] My thought [was
that] they really learnt from this, and I would be surprised
if they did it again [Pharmacist, Group 2]
If your reports are gonna go "Look, this pharmacy's got this
much near misses, ooh, it's a black-listed pharmacy, this
one." But if they're gonna [...] recognise that you've got
these amount of near misses or whatever, this is what you
could do, this what you could do to improve. [...] Is it gonna
be against you or for you in that respect? [Pharmacist,
Group 8]
There's no point in being proactive to a system or manage-
ment or a body which is itself being reactive and discipli-
nary, because that defeats the point of you being proactive
in the first place [Pharmacy owner, Group 10]
The data suggested that pharmacists will engage with any
governance system - whether formal or informal - to the
extent that it supports development of practice rather than
sanctioning individuals or sites. This may reflect the pres-
ence of a pharmacist community of practice - that is, a
social group that fosters collective learning and norms of
practice [30]. Communities of practice tend to be infor-
mal and peer-led, rather than management-led, and so
healthcare professionals may prefer to engage with them
than with formal governance structures [31]. The implica-
tion is that those responsible for managing pharmacists
should be aware of the existence of communities of prac-
tice and work with them, rather than against them, for
mutual benefit.BMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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Protocols
Protocols were recognised to be important in principle, as
they set minimum standards for practice. However, some
participants felt that an over-reliance on protocols ran
counter to their belief in being autonomous professionals.
The protocols are set up because that gives the best chance
of success and the best patient outcome, now you can still
have a good patient outcome even though the protocol's not
been adhered to, but [that could be by] luck [or] whatever
[Pharmacy owner, Group 10]
I know other pharmacists who [...] definitely stick to the
rules, no matter what, and are not gonna bend 'em. Then
some people who kind of just squeeze past them. So it does
depend on the person [Pharmacist, Group 2]
If you've got a patient who's at risk and if you're doing
something or not doing something, then I would ignore [the
protocol] and do what I thought was the professional way,
would be the best thing to do [Pre-registration pharmacist,
Group 5]
I sometimes think they're not very helpful for patients. If
you've got a protocol and you've got to do it a certain way,
but then you can't, say a checking one [...] do you break it
for the benefit of the patient, even though you know you
shouldn't? [Pharmacist, Group 2]
The participants explained that there can sometimes be a
conflict between what a protocol dictates that the pharma-
cist should do and what the pharmacist judges to be the
right thing to do in the situation. It may be the case that a
number of factors play into the decision whether or not to
follow a protocol - for example, the nature of the protocol,
the experience of the pharmacist and the nature of the sit-
uation at hand [19,20]. Nevertheless, deviations from
protocols have been implicated in adverse events in other
healthcare domains [32], and so there is a need to con-
sider the relevance of pharmacy protocols to medication
safety.
Work design
A key feature of the work environment that was reported
to influence pharmacists' work is its physical manifesta-
tion - that is, the layout of the workspace and the equip-
ment that is found within it. New technologies - such as
decision support or automation - may change the nature
of the pharmacist's task activity and demands.
If you've got [...] [a] layout [in] which you're literally right
behind the sales counter you can eavesdrop on pretty much
any conversation, if you've got somebody at the far end of
the shop ringing a bell every time [they're selling] a bottle
of Calpol, then you're less able to intervene [Pharmacy
owner, Group 10]
The "goldfish bowl" dispensary is not a good thing [Locum
pharmacist, Group 9]
You've got to have a tidy dispensary or things do get mud-
dled up and then when you're working fast you're just leap-
ing around, grabbing things off the shelf, and unless things
have been put in the correct place it's so easy [to make a
mistake] [Locum pharmacist, Group 9]
If you start looking at the dispensing process as two stages,
there's the mechanical process and there's the clinical proc-
ess. [...] [If] you divest the two and use [automation] to
take away some of the human error [...] while still allowing
the clinical input [...] you stop worrying so much about
"Am I gonna make errors that are gonna go out to the
patient?" [...] That becomes less of an issue and you start
thinking more about "Hang on a minute, is what's being
dispensed in the best interest of the patient anyway?"
[Pharmacy owner, Group 10]
Szeinbach et al. [11] and Rapport, Doel & Jerzembek [33]
have observed that the topography of community phar-
macists' work areas can either facilitate or interfere with
their practice. For example, Rapport et al. note that a well-
organised workspace engenders a sense of professional-
ism and reduces the likelihood of dispensing error, while
layouts that make pharmacists too accessible to customers
can invite ill-timed interruptions to consultations or dis-
pensing. Respondents to Szeinbach et al.'s survey sug-
gested that the configuration of the pharmacy (that is, its
shape and the presence of a drive-through window) could
affect the efficiency and accuracy of dispensing; automa-
tion, though, was generally felt not to have a negative
impact on efficiency and accuracy. As suggested by the
quotes here, participants in the current study held similar
views about layout to those expressed in these previous
studies. The fourth quote refers to the impact of auto-
mated dispensing; the pharmacist's role - much like other
operators working with closed-loop control systems, such
as pilots and anaesthetists - becomes one of monitor and
decision-maker rather than hands-on assembler. This
change may or may not be welcome to particular pharma-
cists.
Study design: strengths and weaknesses
The use of semi-structured focus groups provided the
researchers with a large volume of rich data about the
experiences of community pharmacy staff. The open-
ended nature of the data collection allowed the partici-
pants to raise other issues that might not have been con-
sidered by the researchers. However, the findings may be
limited in that the sample was confined to communityBMC Health Services Research 2009, 9:158 http://www.biomedcentral.com/1472-6963/9/158
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pharmacy staff working in the North West of England.
While the researchers expect that the findings apply to
pharmacies elsewhere in the United Kingdom, if not inter-
nationally, it is possible that the study has highlighted
some issues that are specific to the geographical location
in which it was conducted. The sample consisted predom-
inantly of locum pharmacists. While a 2002 workforce
survey also indicated a high proportion of locums in com-
parison to other types of pharmacists [34], it is possible
that the views of locums have been given undue predom-
inance in the current study. Support staff and technicians
had relatively little representation in the sample. Also,
there is a time lag of five years between the focus groups
and the publication of the current paper. While the
authors would suggest that the issues raised in this paper
remain of relevance, it is acknowledged that they predate
more recent developments in pharmacy practice such as
extended services (such as supplementary prescribing)
and registered pharmacy technicians (who, unlike many
support staff at the time of the present study, have nation-
ally-recognised formal training and professional accredi-
tation), as well as the forthcoming transfer of pharmacist
regulation to an independent council. Any of these devel-
opments may change the views of pharmacists about soci-
otechnical influences on safety; alternatively, the changes
may be viewed from the perspectives described here. In
any case, what cannot be inferred from this study is the
predictive or causative relationship between any of the
factors indicated and measures of quality or safety. Such a
link should ideally be a focus for future research. One way
of studying this may be to use the factors discussed here as
the basis for a questionnaire, the data from which could
be subjected to factor and regression analysis.
Conclusion
While medication safety might be viewed in terms of the
dispensing process itself, the focus group data from com-
munity pharmacy staff indicate various social and organi-
sational factors that also have a potential impact. Some of
these issues are common to both hospital and community
dispensing. However, others are peculiar to community
pharmacy, in particular the strongly commercial nature of
services in this setting. Either way, it is important to exam-
ine their origin, nature and influence on safety.
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